Modern medicine for our best friends.
Unleash is an animal health platform bridging the gap between human innovation and veterinary therapeutics.
Bridging the gap between human innovation and pet care.
We are living in a golden age of human medicine, yet veterinary therapeutics lag years behind.
Pets are integral family members, but traditional pharma often treats them as a secondary market, leaving veterinarians with limited ability to provide cutting-edge care.
Unleash is a therapeutics engine built to close this gap. We leverage proven human clinical breakthroughs to bring modern, optimized therapeutics to our best friends.
Our therapeutics pipeline
Unleash is advancing a diverse pipeline of therapeutics across high-need veterinary indications. By targeting validated pathways and utilizing human clinical data, we are accelerating the delivery of safer, more effective treatments to the clinic.
Our initial programs focus on oncology, representing the first step in our mission to industrialize veterinary innovation.
FEATURED ASSET
Lead program: UX-001
Indication: Canine osteosarcoma
Mechanism of action: A dual-action immunotherapy combining an autologous vaccine (K9-ACV) with a novel checkpoint inhibitor (CD200AR-L) to stimulate a robust anti-tumor immune response
Status: Clinical. Currently in a multi-center randomized field efficacy study, conducted in partnership with Ardent Animal Health. Learn more about the UX-001 clinical trial >>>